This inventor holds 7 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Reims, Cedex, FR (2013)
- Reims, FR (2013)
- Macclesfield, GB (2015 - 2017)
- Wilmington, DE (US) (2022)
- Cambridge, GB (2023)
Company Filing History:
Years Active: 2013-2025
Title: The Innovations of Sebastien Louis Degorce
Introduction
Sebastien Louis Degorce is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of chemical compounds, holding a total of seven patents. His work primarily focuses on the development of azaquinolone compounds and their applications in medicine.
Latest Patents
Among his latest patents, Sebastien has developed chemical compounds that relate to azaquinolone compounds of Formula (I). These inventions highlight their potential use in medical applications, showcasing his commitment to advancing healthcare through innovative solutions.
Career Highlights
Sebastien is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Sebastien has worked alongside notable colleagues, including Christine Marie Paul Lambert-Van Der Brempt and Patrick Ple. These collaborations have further enriched his research and innovation efforts.
Conclusion
Sebastien Louis Degorce's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile